BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Ipilimumab
1
Tsunami of immunotherapy reaches mesothelioma
4/22/2022 8:49:02 AM | Browse: 419 | Download: 875
2
Immune checkpoint inhibitors induced colitis, stay vigilant: A case report
6/15/2020 8:19:14 AM | Browse: 986 | Download: 1362
3
Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report
10/25/2019 8:06:40 AM | Browse: 759 | Download: 1208
4
Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report
1/21/2019 9:20:19 AM | Browse: 1099 | Download: 1527
5
Endoscopic evaluation of immunotherapy-induced gastrointestinal toxicity
12/21/2018 6:09:14 AM | Browse: 948 | Download: 1514
6
Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis
3/19/2017 6:44:00 PM | Browse: 1164 | Download: 2446
7
Ipilimumab associated colitis: An IpiColitis case series at MedStar Georgetown University Hospital
4/15/2015 11:01:00 AM | Browse: 1183 | Download: 1624
8
Present and future of immune checkpoint blockade: Monotherapy to adjuvant approaches
3/31/2015 10:55:00 AM | Browse: 1228 | Download: 1257
9
Diarrhoea in a patient with metastatic melanoma: Ipilimumab ileocolitis treated with infliximab
9/5/2014 2:19:00 PM | Browse: 1041 | Download: 956
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345